Saito, S.; Kawashima, Y.; Tanaka, H.; Yoshimura, N.; Tsukita, Y.; Saito, R.; Nakagawa, T.; Inomata, M.; Nagashima, H.; Sugawara, S.
Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901. Cancers 2025, 17, 1551.
https://doi.org/10.3390/cancers17091551
AMA Style
Saito S, Kawashima Y, Tanaka H, Yoshimura N, Tsukita Y, Saito R, Nakagawa T, Inomata M, Nagashima H, Sugawara S.
Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901. Cancers. 2025; 17(9):1551.
https://doi.org/10.3390/cancers17091551
Chicago/Turabian Style
Saito, Shin, Yosuke Kawashima, Hisashi Tanaka, Naruo Yoshimura, Yoko Tsukita, Ryota Saito, Taku Nakagawa, Minehiko Inomata, Hiromi Nagashima, and Shunichi Sugawara.
2025. "Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901" Cancers 17, no. 9: 1551.
https://doi.org/10.3390/cancers17091551
APA Style
Saito, S., Kawashima, Y., Tanaka, H., Yoshimura, N., Tsukita, Y., Saito, R., Nakagawa, T., Inomata, M., Nagashima, H., & Sugawara, S.
(2025). Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901. Cancers, 17(9), 1551.
https://doi.org/10.3390/cancers17091551
